Carolyn Schutt Ibsen, Ph.D.
Assistant Professor |
Biomedical Engineering Department |
The Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR) |
Oregon Health and Science University |
Seminar Information

As engineered tissues become ever more spatially complex through advanced biofabrication techniques, there is a critical need to also coordinate the temporal complexity of cell behavior. Advancements in disease modeling and regenerative therapies require the ability to direct cell processes within these structures after they are formed and throughout their maturation. This direction can be achieved by manipulating the protein presentation of selected cells within 3D scaffolds through targeted gene expression. However, these dynamic genetic perturbations are challenging to remotely coordinate in fully formed biofabricated tissues using traditional gene delivery methods. To address this challenge, our team has pioneered development of ultrasound-responsive cell culture platforms (SonoScaffolds) for noninvasive and spatiotemporally-controlled genetic manipulation of cells in 3D tissue constructs. Our approach utilizes focused ultrasound as an external non-invasive trigger for biomaterial-mediated gene delivery with unique advantages due to its significant penetration depth and ability to be focused to small volumes within tissue.
Our work demonstrates the use of SonoScaffolds for controlled delivery of multiple genes in user-defined locations of scaffolds and heterogeneous 3D-bioprinted structures, including ultrasound-patterned vascular growth factor expression. We show controlled HER2 oncogene overexpression in individual cells within matrix-embedded mammary spheroids for studying interactions with surrounding healthy cells in early-stage disease. We are also extending this technology to develop vascularized and organ-on-chip models. As these dynamic 3D tissue constructs become larger and more intricate, there is also a need to develop non-destructive tools for monitoring cell state. These “sentinels” consist of embedded optical metabolic nanosensors and microwave-assisted immunofluorescence staining techniques for 3D culture. Together, this work presents a new class of 3D-programmable cell culture materials that enable researchers to control the temporal coordination of cell processes, with important applications in disease modeling and tissue regeneration.
Dr. Carolyn Schutt Ibsen is an Assistant Professor in the Department of Biomedical Engineering and the Knight Cancer Institute at Oregon Health and Science University (OHSU), where she leads the Energy-Responsive Biomaterials Lab. Her research group focuses on developing ultrasound-active materials that can be remote-controlled for directing tissue regeneration and modeling cancer progression. Dr. Schutt Ibsen is the recipient of the 2024 NSF CAREER Award and the NIH R35 Maximizing Investigator’s Research Award with additional research support from the Kuni Foundation and the Knight Cancer Early Detection Advanced Research Center. Additionally, she has been recognized as a 2024 Cellular and Molecular Bioengineering (CMBE) Young Innovator and received the 2023 Biomedical Engineering Society Cellular and Molecular Bioengineering (BMES-CMBE) Rising Star Award. She has served on the International Alliance for Cancer Early Detection Training and Education Working Group and has co-directed international meeting symposia on stimuli-responsive biomaterials and emerging applications of ultrasound in regenerative medicine. Prior to OHSU, Dr. Schutt Ibsen was a Whitaker International Postdoctoral Fellow in biomaterials and tissue engineering in the group of Prof. Dame Molly Stevens at Imperial College London, and served as the principal bioengineer of a nanomedicine start-up company. Dr. Schutt Ibsen holds a Ph.D. in Bioengineering from UC San Diego, where she was a Siebel Scholar, NSF Graduate Research Fellow, Gordon Engineering Leadership Fellow, and recipient of the Shunichi Usami Memorial Ph.D. Thesis Award.